143 related articles for article (PubMed ID: 33826891)
1. FoxO1 inhibition alleviates type 2 diabetes-related diastolic dysfunction by increasing myocardial pyruvate dehydrogenase activity.
Gopal K; Al Batran R; Altamimi TR; Greenwell AA; Saed CT; Tabatabaei Dakhili SA; Dimaano MTE; Zhang Y; Eaton F; Sutendra G; Ussher JR
Cell Rep; 2021 Apr; 35(1):108935. PubMed ID: 33826891
[TBL] [Abstract][Full Text] [Related]
2. FoxO1 regulates myocardial glucose oxidation rates via transcriptional control of pyruvate dehydrogenase kinase 4 expression.
Gopal K; Saleme B; Al Batran R; Aburasayn H; Eshreif A; Ho KL; Ma WK; Almutairi M; Eaton F; Gandhi M; Park EA; Sutendra G; Ussher JR
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H479-H490. PubMed ID: 28687587
[TBL] [Abstract][Full Text] [Related]
3. The GLP-1 Receptor Agonist Liraglutide Increases Myocardial Glucose Oxidation Rates via Indirect Mechanisms and Mitigates Experimental Diabetic Cardiomyopathy.
Almutairi M; Gopal K; Greenwell AA; Young A; Gill R; Aburasayn H; Al Batran R; Chahade JJ; Gandhi M; Eaton F; Mailloux RJ; Ussher JR
Can J Cardiol; 2021 Jan; 37(1):140-150. PubMed ID: 32640211
[TBL] [Abstract][Full Text] [Related]
4. FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes.
Yan D; Cai Y; Luo J; Liu J; Li X; Ying F; Xie X; Xu A; Ma X; Xia Z
J Cell Mol Med; 2020 Jul; 24(14):7850-7861. PubMed ID: 32450616
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin IV attenuates diabetic cardiomyopathy
Zhang M; Sui W; Xing Y; Cheng J; Cheng C; Xue F; Zhang J; Wang X; Zhang C; Hao P; Zhang Y
Theranostics; 2021; 11(18):8624-8639. PubMed ID: 34522203
[No Abstract] [Full Text] [Related]
6. Increasing Pyruvate Dehydrogenase Flux as a Treatment for Diabetic Cardiomyopathy: A Combined 13C Hyperpolarized Magnetic Resonance and Echocardiography Study.
Le Page LM; Rider OJ; Lewis AJ; Ball V; Clarke K; Johansson E; Carr CA; Heather LC; Tyler DJ
Diabetes; 2015 Aug; 64(8):2735-43. PubMed ID: 25795215
[TBL] [Abstract][Full Text] [Related]
7. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation.
Mori J; Patel VB; Abo Alrob O; Basu R; Altamimi T; Desaulniers J; Wagg CS; Kassiri Z; Lopaschuk GD; Oudit GY
Circ Heart Fail; 2014 Mar; 7(2):327-39. PubMed ID: 24389129
[TBL] [Abstract][Full Text] [Related]
9. Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation.
Gopal K; Karwi QG; Tabatabaei Dakhili SA; Wagg CS; Zhang L; Sun Q; Saed CT; Panidarapu S; Perfetti R; Ramasamy R; Ussher JR; Lopaschuk GD
Cardiovasc Diabetol; 2023 Mar; 22(1):73. PubMed ID: 36978133
[TBL] [Abstract][Full Text] [Related]
10. KLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy.
Kyriazis ID; Hoffman M; Gaignebet L; Lucchese AM; Markopoulou E; Palioura D; Wang C; Bannister TD; Christofidou-Solomidou M; Oka SI; Sadoshima J; Koch WJ; Goldberg IJ; Yang VW; Bialkowska AB; Kararigas G; Drosatos K
Circ Res; 2021 Feb; 128(3):335-357. PubMed ID: 33539225
[TBL] [Abstract][Full Text] [Related]
11. Exogenous hydrogen sulfide attenuates the development of diabetic cardiomyopathy via the FoxO1 pathway.
Ye P; Gu Y; Zhu YR; Chao YL; Kong XQ; Luo J; Ren XM; Zuo GF; Zhang DM; Chen SL
J Cell Physiol; 2018 Dec; 233(12):9786-9798. PubMed ID: 30078216
[TBL] [Abstract][Full Text] [Related]
12. Kir6.1 improves cardiac dysfunction in diabetic cardiomyopathy via the AKT-FoxO1 signalling pathway.
Wang J; Bai J; Duan P; Wang H; Li Y; Zhu Q
J Cell Mol Med; 2021 Apr; 25(8):3935-3949. PubMed ID: 33547878
[TBL] [Abstract][Full Text] [Related]
13. Pyruvate dehydrogenase influences postischemic heart function.
Lewandowski ED; White LT
Circulation; 1995 Apr; 91(7):2071-9. PubMed ID: 7895366
[TBL] [Abstract][Full Text] [Related]
14. Effects of increased cardiac work on pyruvate dehydrogenase activity in hearts from diabetic animals.
Kobayashi K; Neely JR
J Mol Cell Cardiol; 1983 Jun; 15(6):347-57. PubMed ID: 6876184
[TBL] [Abstract][Full Text] [Related]
15. FOXO1 inhibition synergizes with FGF21 to normalize glucose control in diabetic mice.
Lee YK; Diaz B; Deroose M; Lee SX; Belvedere S; Accili D; Leibel RL; Lin HV
Mol Metab; 2021 Jul; 49():101187. PubMed ID: 33577983
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial aldehyde dehydrogenase 2 deficiency aggravates energy metabolism disturbance and diastolic dysfunction in diabetic mice.
Wang C; Fan F; Cao Q; Shen C; Zhu H; Wang P; Zhao X; Sun X; Dong Z; Ma X; Liu X; Han S; Wu C; Zou Y; Hu K; Ge J; Sun A
J Mol Med (Berl); 2016 Nov; 94(11):1229-1240. PubMed ID: 27488451
[TBL] [Abstract][Full Text] [Related]
17. FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate.
Piao L; Sidhu VK; Fang YH; Ryan JJ; Parikh KS; Hong Z; Toth PT; Morrow E; Kutty S; Lopaschuk GD; Archer SL
J Mol Med (Berl); 2013 Mar; 91(3):333-46. PubMed ID: 23247844
[TBL] [Abstract][Full Text] [Related]
18. Activation of Foxo1 by insulin resistance promotes cardiac dysfunction and β-myosin heavy chain gene expression.
Qi Y; Zhu Q; Zhang K; Thomas C; Wu Y; Kumar R; Baker KM; Xu Z; Chen S; Guo S
Circ Heart Fail; 2015 Jan; 8(1):198-208. PubMed ID: 25477432
[TBL] [Abstract][Full Text] [Related]
19. Cardiac-Specific Deletion of Pyruvate Dehydrogenase Impairs Glucose Oxidation Rates and Induces Diastolic Dysfunction.
Gopal K; Almutairi M; Al Batran R; Eaton F; Gandhi M; Ussher JR
Front Cardiovasc Med; 2018; 5():17. PubMed ID: 29560354
[TBL] [Abstract][Full Text] [Related]
20. QKI deficiency promotes FoxO1 mediated nitrosative stress and endoplasmic reticulum stress contributing to increased vulnerability to ischemic injury in diabetic heart.
Guo W; Jiang T; Lian C; Wang H; Zheng Q; Ma H
J Mol Cell Cardiol; 2014 Oct; 75():131-40. PubMed ID: 25068621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
